Feb 9 • 13:57 UTC 🇷🇺 Russia RT

Spanish PM’s party crushed in regional election

Spanish Prime Minister Pedro Sanchez's Socialist Party faced a significant defeat in the Aragon regional election, marking a trend of declining support for the government.

In a significant setback for Spanish Prime Minister Pedro Sanchez, his Socialist Party suffered a crushing defeat in the Aragon regional election. The conservative People's Party (PP) emerged as the front-runner, securing 26 seats in the 67-member regional parliament, although it fell short of an outright majority with 34.3% of the vote. Meanwhile, Sanchez's Socialists experienced a dramatic decline, falling to 18 seats from their previous 23, which represents their worst result ever in this region, with only 24.3% of the vote. The right-wing Vox party also saw substantial gains, doubling their presence with 14 seats, finishing in third place.

The election results are seen as indicative of the shifting political landscape in Spain, particularly in regions traditionally viewed as indicators of national sentiment, with Aragon often referred to as "Spain's Ohio." The loss highlights the government's waning popularity and sets a concerning precedent as Sanchez's administration grapples with challenges related to governance and public sentiment. Pilar Alegria, the Socialist candidate who resigned from her role as education minister to contest in the elections, acknowledged the disappointing outcomes, suggesting that this electoral defeat has opened the door to an uncertain future for Aragon's governance.

This regional election is the first of three anticipated in regions governed by the People’s Party, raising further questions about the implications of these results for the national political scene. As the political climate continues to evolve, the outcome of this election may provide insights into the potential shifts in voter sentiment ahead of future national engagements, particularly amid ongoing economic and social challenges facing the Spanish government.

📡 Similar Coverage